A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
Clinical trial NCT03355794 · COMPLETED
Trial details
- NCT number
- NCT03355794
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-14
- Primary completion
- 2020-07-31
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.